The effect of estrogens and antiestrogens in rat models of hot flush.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 182, doi. 10.1002/ddr.20057
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2005 AND VI 66 AND IP 2
Results: 13
1
2
Neuroprotection by estrogen in animal models of ischemia and Parkinson's disease.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 172, doi. 10.1002/ddr.20056
- By:
- Publication type:
- Article
3
17β‐ and 17α‐estradiol are non‐competitive inhibitors of dopamine uptake: implications for Parkinson's disease models and therapeutics.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 160, doi. 10.1002/ddr.20055
- By:
- Publication type:
- Article
4
Estrogen replacement and cognition in postmenopausal women: effect of years since menopause on response to treatment.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 150, doi. 10.1002/ddr.20054
- By:
- Publication type:
- Article
5
Estradiol‐induced enhancement in cell proliferation is mediated through estrogen receptors in the dentate gyrus of adult female rats.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 142, doi. 10.1002/ddr.20053
- By:
- Publication type:
- Article
6
Lack of protective effect of estrogens on cerebral Aβ levels in intact female and male APP transgenic mice.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 136, doi. 10.1002/ddr.20052
- By:
- Publication type:
- Article
7
A major role for astrocytes in the neuroprotective effect of estrogen.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 126, doi. 10.1002/ddr.20051
- By:
- Publication type:
- Article
8
Mechanistic insights into the direct antioxidant effects of estrogens.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 118, doi. 10.1002/ddr.20050
- By:
- Publication type:
- Article
9
Estrogen receptor β as a therapeutic target for promoting neurogenesis and preventing neurodegeneration.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 103, doi. 10.1002/ddr.20049
- By:
- Publication type:
- Article
10
Mapping the locations of estradiol and potent neuroprotective analogues in phospholipid bilayers by REDOR.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 93, doi. 10.1002/ddr.20048
- By:
- Publication type:
- Article
11
Neuroprotective effects of estratriene analogs: structure‐activity relationships and molecular optimization.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 78, doi. 10.1002/ddr.20047
- By:
- Publication type:
- Article
12
Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 53, doi. 10.1002/ddr.20046
- By:
- Publication type:
- Article
13
Estrogens and Neuroprotection: desperate housewives, lost, and survivor.
- Published in:
- Drug Development Research, 2005, v. 66, n. 2, p. 51, doi. 10.1002/ddr.20045
- By:
- Publication type:
- Article